Purchase Order HT942524P0047
Award Date
2/11/24
Potential Completion Date
9/11/24
Potential Value
$250K
Federal Agency
Defense Health Agency
Awardee
Emergingdx Inc.
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Mansfield, MA 02048, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
122
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed
Similar Awards
This STTR Phase I contract, valued at $246,350.00, was awarded by the Office of Naval Research (ONR), a defense agency, to Emergingdx Inc., a small business subchapter S corporation based in Mansfield, Massachusetts. The contract is set aside for small businesses. Emergingdx Inc. specializes in developing advanced diagnostic and biosensor technologies for disease detection and precision medicine applications, with a focus on early disease detection, biomarker analysis, and rapid diagnostic...
This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the Defense Health Agency (DHA) to Emergingdx Inc., a small business based in Mansfield, Massachusetts. The contract, valued at $1,299,988.98, supports the development of an automated detection platform for circulating and exosomal microRNAs. This research and development effort is focused on medical diagnostics and aligns with the DHA's mission to advance healthcare technologies. The contract was awarded on...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Defense Health Agency (DHA) to Firebird Biomolecular Sciences LLC, a for-profit limited liability company, for the development of "Innovative DNA for Highly Multiplexed Molecular Diagnostics". The $249,956.88 firm-fixed-price contract has a period of performance ending on May 8, 2025. The contract supports research and development of novel molecular technologies to create a rapid, point-of-sampling...
This is a $999,923 Small Business Innovation Research (SBIR) Phase II contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Inflammatix, Inc., a small disadvantaged business in Sunnyvale, California. The contract is for the development of point-of-care diagnostic solutions to monitor the host-pathogen interaction during infection. Inflammatix has been awarded over $29 million in federal contracts and grants from agencies like the Department of Health and Human Services and...
<p>The U.S. Air Force Research Laboratory (AFRL) awarded a Small Business Innovation Research (SBIR) Phase II contract worth $1,249,994.00 to Dxlab Inc., a for-profit organization, for the development of a portable and rugged infection diagnostic platform that provides rapid, clinically actionable pathogen detection at deployed locations and military treatment facilities. The contract has a total small business set-aside designation and is set to be completed by December 8, 2025.</p>
This Small Business Innovation Research Phase I contract was awarded by the National Institutes of Health National Institute of Allergy and Infectious Diseases to Giner Inc. for $299,949. The contract calls for the development of a low-cost and robust nucleic acid sensor instrument that can rapidly and accurately identify the presence of dimorphic fungal species to yield early and definitive diagnosis of endemic fungal diseases such as histoplasmosis and coccidioidomycosis. The contract responds...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Mbio Diagnostics Inc., doing business as Lightdeck Diagnostics, for the development of a "Point of Care Host-Pathogen Monitoring System." The fixed-price contract has a ceiling value of $149,503.39 and was awarded on November 18, 2016, with a completion date of November 27, 2017. Mbio Diagnostics Inc. is a for-profit organization that develops...
This $243,500 firm-fixed-price purchase order was awarded to Instadiagnostics Inc., a minority-owned, for-profit small business, by the Centers for Disease Control and Prevention (CDC) under the Small Business Innovation Research (SBIR) program. The contract is for the development of rapid diagnostic tests and devices related to SBIR Topic 37. Instadiagnostics Inc. has previously received federal grants from the CDC, Department of Defense, and National Institutes of Health for the development of...
Earlydiagnostics Inc., doing business as Earlydx, was awarded a $395,918 firm fixed price contract by the National Institutes of Health National Cancer Institute under the Small Business Innovation Research program. The contract has a total small business set aside designation. Earlydx will provide cloud-based development of a liquid-biopsy platform for the Cancer Research Data Commons, as requested in Topic 428 of the NIH/CDC SBIR solicitation seeking proposals for next generation...
<p>This federal contract award W81XWH15C0163 was issued by the U.S. Army Medical Command (MEDCOM) to Dxdiscovery Inc., a small business concern, under the Small Business Innovation Research (SBIR) program. The $149,714.90 firm-fixed-price contract is for Phase I of an SBIR project with a completion date of April 28, 2016. The contract is a definitive contract and has a total small business set-aside designation.</p>